{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:43:29Z","timestamp":1788957809938,"version":"build-2803163510"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0216485","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T17:27:33Z","timestamp":1559755653000},"page":"e0216485","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Understanding heterogeneous tumor microenvironment in metastatic melanoma"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9238-4325","authenticated-orcid":true,"given":"Yiyi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Leontovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gerdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Santamaria-Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-6903","authenticated-orcid":true,"given":"Aaron S.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrystal","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K.","family":"Nevala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Flotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Ginty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetomir N.","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma","volume":"33","author":"D Schadendorf","year":"2015","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune Checkpoint Blockade in Cancer Therapy","volume":"33","author":"MA Postow","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9948","key":"ref3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial","volume":"384","author":"C Robert","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"FS Hodi","year":"2010","journal-title":"N Engl J Med"},{"issue":"21","key":"ref5","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","author":"MA Postow","year":"2015","journal-title":"N Engl J Med"},{"issue":"7528","key":"ref6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"PC Tumeh","year":"2014","journal-title":"Nature"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"A Gros","year":"2014","journal-title":"J Clin Invest"},{"issue":"32","key":"ref8","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1200\/JCO.2012.47.7521","article-title":"Tumor exome analysis reveals neoantigen-specific T-cell reactivity in an ipilimumab-responsive melanoma","volume":"31","author":"N van Rooij","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.humpath.2011.12.013","article-title":"Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer","volume":"43","author":"R Yamaguchi","year":"2012","journal-title":"Hum Pathol"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1158\/1078-0432.CCR-15-0715","article-title":"PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma","volume":"22","author":"F Sabbatino","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ymeth.2014.08.016","article-title":"Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis","volume":"70","author":"EC Stack","year":"2014","journal-title":"Methods"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nm.3488","article-title":"Multiplexed ion beam imaging of human breast tumors","volume":"20","author":"M Angelo","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/labinvest.2015.2","article-title":"Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging","volume":"95","author":"RM Levenson","year":"2015","journal-title":"Lab Invest"},{"issue":"29","key":"ref14","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1073\/pnas.1300136110","article-title":"Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue","volume":"110","author":"MJ Gerdes","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3389\/fonc.2014.00366","article-title":"Emerging understanding of multiscale tumor heterogeneity","volume":"4","author":"MJ Gerdes","year":"2014","journal-title":"Front Oncol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93487","article-title":"Optimized multiplex immunofluorescence single-cell analysis reveals tuft cell heterogeneity","volume":"2","author":"ET McKinley","year":"2017","journal-title":"JCI Insight"},{"key":"ref17","unstructured":"Sood A, Kenny, KB., Natarajan, A., Kaanumalle, LS. Method of analyzing H&amp;E stained biological sample. US patent 9176032 B2."},{"key":"ref18","unstructured":"al AS-Pe. Robust single cell quantification of immune cell subtypes in histological samples. 2017 IEEE EMBS International Conference on Biomedical &amp; Health Informatics (BHI), Orlando, FL, 2017. 2017:pp. 121\u2013124."},{"key":"ref19","unstructured":"A Sood FG, NE LaPlante, CJ Sevinsky, Q Li, A Santamaria-Pang. Method and system for classification and quantitative analysis of cell types in microscopy images. US Patent 9,984,199."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10582","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"DB Johnson","year":"2016","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"ref21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1399-0039.2006.774_2.x","article-title":"HLA expression and cancer\u201414th IHIWS immunohistochemistry quality control exercise exchange results","volume":"69","author":"SF Chew","year":"2007","journal-title":"Tissue Antigens"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1158\/1078-0432.CCR-07-4433","article-title":"HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma","volume":"14","author":"LY Han","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0167-5699(93)90264-L","article-title":"Natural history of HLA expression during tumour development","volume":"14","author":"F Garrido","year":"1993","journal-title":"Immunol Today"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","article-title":"Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance","volume":"74","author":"FM Marincola","year":"2000","journal-title":"Adv Immunol"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","article-title":"PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression","volume":"6","author":"X Xiao","year":"2016","journal-title":"Cancer Discov"},{"key":"ref26","article-title":"MKA. Handbook of Spatial Poin-Pattern Analysis in Ecology","author":"T Wiegand","year":"2014"},{"key":"ref27","article-title":"Statistical Analysis and Modelling of Spatial Point Patterns","author":"JB Illian","year":"2008"},{"key":"ref28","article-title":"Spatial Point Patterns: Methodology and Applications with R","author":"A. RE Baddeley","year":"2016"},{"issue":"6","key":"ref29","first-page":"1","article-title":"TR. Spatstat: An R Package for Analyzing Spatial Point Patterns","volume":"12","author":"A Baddley","year":"2005","journal-title":"J Stat Softw"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma","volume":"375","author":"JM Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.23543","article-title":"Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression","volume":"123","author":"IS van Houdt","year":"2008","journal-title":"Int J Cancer"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)65321-7","article-title":"Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression","volume":"154","author":"T Kageshita","year":"1999","journal-title":"Am J Pathol"},{"issue":"7385","key":"ref33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nature10755","article-title":"Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting","volume":"482","author":"H Matsushita","year":"2012","journal-title":"Nature"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nm.3161","article-title":"Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells","volume":"19","author":"PF Robbins","year":"2013","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"T Boon","year":"1994","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.183.3.725","article-title":"Human tumor antigens recognized by T lymphocytes","volume":"183","author":"T Boon","year":"1996","journal-title":"J Exp Med"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","article-title":"T cell defined tumor antigens","volume":"9","author":"BJ Van den Eynde","year":"1997","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/0008-5472.CAN-06-0029","article-title":"Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2\/neu-specific immunity","volume":"66","author":"H Norell","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"ref39","first-page":"47","article-title":"Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer","volume":"2","author":"A Concha","year":"1991","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/1097-0142(19911215)68:12<2591::AID-CNCR2820681212>3.0.CO;2-L","article-title":"Expression of class I histocompatibility antigens in transitional cell carcinoma of the urinary bladder in relation to survival","volume":"68","author":"I Levin","year":"1991","journal-title":"Cancer"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.26471","article-title":"Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes","volume":"131","author":"R Carretero","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00262-006-0166-2","article-title":"Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy","volume":"56","author":"R Mendez","year":"2007","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijc.21163","article-title":"Total loss of MHC class I is an independent indicator of good prognosis in breast cancer","volume":"117","author":"Z Madjd","year":"2005","journal-title":"Int J Cancer"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1158\/1078-0432.CCR-06-2087","article-title":"Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer","volume":"13","author":"P Rolland","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"15","key":"ref45","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1158\/1078-0432.CCR-06-0595","article-title":"Effect of human leukocyte antigen class I expression of tumor cells on outcome of intravesical instillation of bacillus calmette-guerin immunotherapy for bladder cancer","volume":"12","author":"H Kitamura","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bjc.6605315","article-title":"Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy","volume":"101","author":"M Shehata","year":"2009","journal-title":"Br J Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0216485","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:53:08Z","timestamp":1589039588000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0216485"}},"subtitle":[],"editor":[{"given":"Fabrizio","family":"Mattei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0216485","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]}}}